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Self-renewal and pluripotency of embryonic stem (ES) cells are maintained by several signaling cascades and by expression of
intrinsic factors, such as Oct4, Nanog and Sox2. The mechanism regulating these signaling cascades in ES cells is of great
interest. Recently, we have demonstrated that natriuretic peptide receptor A (NPR-A), a speciﬁc receptor for atrial and brain
natriuretic peptides (ANP and BNP, respectively), is expressed in pre-implantation embryos and in ES cells. Here, we examined
whether NPR-AisinvolvedinthemaintenanceofEScellpluripotency.RNA interference-mediatedknockdownofNPR-A resulted
in phenotypic changes, indicative of differentiation, downregulation of pluripotency factors (such as Oct4, Nanog and Sox2) and
upregulation of differentiation genes. NPR-A knockdown also resulted in a marked downregulation of phosphorylated Akt.
Furthermore, NPR-A knockdown induced accumulation of ES cells in the G1 phase of the cell cycle. Interestingly, we found that
ANP was expressed in self-renewing ES cells, whereas its level was reduced after ES cell differentiation. Treatment of ES cells
with ANP upregulated the expression of Oct4, Nanog and phosphorylated Akt, and this upregulation depended on NPR-A
signaling, because it was completely reversed by pretreatment with either an NPR-A antagonist or a cGMP-dependent protein
kinase inhibitor. These ﬁndings provide a novel role for NPR-A in the maintenance of self-renewal and pluripotency of ES cells.
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Embryonic stem (ES) cells are pluripotent and self-renewing
cells generated by cellular outgrowth of pre-implantation
embryos.
1,2 They have the ability to differentiate into the
representative cell types of all three germ layers of the
embryo.
3 These unique properties make them exceptionally
valuable for cell replacement therapies and for regenerative
medicine, and control of self-renewal and pluripotency of ES
cells is important for their potential.
ThepluripotentidentityofEScellsiscontrolledbyagroupof
transcription factors.
4–8 Within this group, the transcription
factors Oct4, Nanog and Sox2 contribute to the hallmark
characteristics of ES cells by activation of target genes that
encodepluripotencyandself-renewalmechanisms,aswellas
by repression of signaling pathways that promote differentia-
tion.
8 In addition, ES cell pluripotency requires inputs from
extrinsic factors and their downstream effectors.
9 However,
the molecular mechanisms that control pluripotency and
differentiation of ES cells are largely unknown. Therefore,
it is important to elucidate the transcriptional networks
surrounding Oct4, Nanog and Sox2.
Natriuretic peptide receptor A (NPR-A) is the receptor for
atrial natriuretic peptide (ANP) and brain natriuretic peptide
(BNP). ANP and BNP, members of the natriuretic peptide
family, have been extensively studied for their functions in
regulating blood pressure.
10,11 In addition to this cardiovas-
cular proﬁle, there is evidence that suggests that ANP can
also act as an autocrine/paracrine factor.
12 Previous studies
have reported that ANP has apoptotic,
13 anti-apoptotic, anti-
hypertrophic,
14 anti-mitogenic
15 and mitogenic
16 effects, and
has a role in tumor cell growth.
17 Both ANP and BNP signal
through NPR-A or natriuretic peptide receptor B (NPR-B) by
increasing cGMP and by activating cGMP-dependent protein
kinase (PKG), which in turn can activate different downstream
effectors involved in cell growth, apoptosis, proliferation and
inﬂammation.
10,18 ANP does not bind to NPR-B, but some
mitogenic effects of BNP are mediated through its binding to
NPR-B.
19
Previous studies with mice using genetic disruption of the
NPR-A gene have been widely used to examine the role of
natriuretic peptide signaling in cardiac functions.
20–22 These
studies focused on the effect of disrupted NPR-A in adult
animals only. However, a critical requirement of NPR-A
in early development has been recently documented.
23
Recently, we showed that NPR-A is expressed at high levels
in pre-implantation embryos and in undifferentiated murine ES
cells, which is rapidly downregulated after their differentiation,
24
suggestinginvolvementofNPR-Ainregulatingearlydevelopment.
As no role has been established for NPR-A in ES cells, we
aimed to selectively knock down NPR-A expression in murine
ES cells using an RNA interference approach to evaluate its
role in self-renewal and pluripotency of ES cells. Furthermore,
we examined the effect of exogenous ANP on ES cell
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knockdown of NPR-A in murine ES cells results in differentia-
tion of ES cells in the presence of the leukemia-inhibitory
factor (LIF). Conversely, exogenous ANP activated the
expression of the pluripotency factors, Oct4 and Nanog,
through the NPR-A pathway.
Results
Knockdown of NPR-A leads to loss of self-renewal and
pluripotency in ES cells. Previously, we have shown that
NPR-A is speciﬁcally expressed in undifferentiated ES
cells.
24 To conﬁrm these data, we examined the expression
of NPR-A under self-renewal and differentiation conditions.
Double-immunoﬂuorescence analysis showed that NPR-A
was highly expressed in undifferentiated ES (Oct4-positive)
cells, which were cultured in the presence of LIF, and that
expression was downregulated upon differentiation induced
by culturing ES cells without LIF for 5 days. Differentiated
cells, which were negative for Oct4 expression, were also
negative for NPR-A expression (Supplementary Figure 1),
indicating that NPR-A is speciﬁcally expressed in self-
renewing ES cells.
To determine the role of NPR-A in murine ES cells, a small-
interfering RNA (siRNA)-based technique using two indepen-
dent siRNAs targeting different regions of NPR-A mRNA was
used to speciﬁcally knock down the NPR-A gene in ES cells
maintained in a feeder-free culture. Before siRNA transfection,
the undifferentiated status of murine ES cells used for
transfection was conﬁrmed by ﬂow cytometry and immuno-
ﬂuorescence (for Oct4-positive cells) (data not shown). Knock-
downefﬁciencywasanalyzedat48haftertransfectionofsiRNA.
Both reverse transcription-PCR (RT-PCR) and real-time
PCR revealed a marked reduction in the level of NPR-A
mRNA at 48h after transfection in ES cells, which were
transfected with NPR-A-targeting siRNA (NPR-A siRNA),
compared with ES cells that were transfected with a
nontargeting siRNA (control siRNA) (Figures 1a and b). This
ﬁnding was conﬁrmed by a reduction in protein levels
observed in western blots (Figure 1c).
We also evaluated colony morphology and alkaline
phosphatase (AP) activity in ES cells cultured in the presence
of LIF. Two days after transfection, NPR-A siRNA-treated
cells exhibited a striking change in morphology with the
presence ofcolonies composedofmuchlarger, ﬂattened cells
typical of differentiating cells (Figure 2a). AP staining, which is
indicative of the self-renewal property of ES cells, was
markedly reduced in ES cells treated with NPR-A siRNA in
comparison with those treated with control siRNA (Figure 2b).
Next,weexaminedtheexpressionofthepluripotencyfactor
Oct4 by immunostaining at 72h after siRNA transfection. As
shown in Figure 2c, Oct4 expression was decreased in ES
cells treated with NPR-A siRNA than in control siRNA-treated
cells. To provide a more quantitative analysis, we used
immunoblotting to examine the expression of Oct4 and
Nanog. We found that NPR-A siRNA-treated cells showed a
marked reduction in the level of Oct4 and Nanog, which are
themasterregulatorsofEScellself-renewalandpluripotency,
compared with control siRNA-treated cells (Figure 2d). Both
siRNAs targeting NPR-A caused a similar change in
morphology, AP staining, Oct4 expression and Nanog
expression (Figures 2a–d).
To examine the self-renewal of NPR-A knockdown ES cells
at the single cell level, 2 days after siRNA transfection, ES
cells were seeded at low density (1000 or 2000 cells per
35-mm dish) in the presence of LIF for 6 days to form
secondaryEScellcolonies(Figure2e).Thenumberofformed
colonies of NPR-A siRNA-treated ES cells was signiﬁcantly
reduced than that of control siRNA-treated cells, and the
majority of colonies formed by NPR-A siRNA-treated cells
appeared differentiated when compared with control siRNA-
treated cells. To conﬁrm these results, AP staining was
performed (Figure 2f). Quantiﬁcation of AP-positive colonies
showed that 490% of control siRNA-treated cells were
undifferentiated,whereasNPR-AsiRNA-treatedcellsshowed
a signiﬁcant decrease in the proportion of undifferentiated
colonies (B46%) (Figure 2f). These ﬁndings suggest that
NPR-A is important for self-renewal of ES cells.
NPR-A knockdown downregulates pluripotency genes
and upregulates differentiation genes in murine ES
cells. To assess the differentiation state of NPR-A
knockdown cells, we assayed for changes in the
expression of key pluripotency genes (such as Oct4,
Nanog and Sox2) that are considered a part of the core set
of factors associated with the maintenance of pluripotency
and self-renewal in ES cells.
4–7 RT-PCR and real-time PCR
analyses of all these genes showed a decreased level of
expression in NPR-A-deﬁcient cells when compared with
control siRNA-treated cells (Figures 3a and b). These results
indicate that NPR-A has a role in regulating ES cell
pluripotency genes.
Wethenexaminedchangesintheexpressionlevelsofearly
differentiation marker genes such as GATA-4 and GATA-6 for
the extraembryonic endoderm, AFP for the visceral endo-
derm, Brachyury for mesoderm, nestin for ectoderm and
Cdx2, Hand1 and Eomes for trophectoderm. All these genes
Figure 1 NPR-A small-interfering RNA (siRNA) induces efﬁcient knockdown of
NPR-A in murine ES cells. (a) RT-PCR analysis of ES cells transfected with control
siRNA or NPR-A siRNAs, showing knockdown of the NPR-A gene 48h after siRNA
transfection. GAPDH was used as the internal control. (b) Real-time PCR analysis
ofEScellstreatedwithcontrolsiRNAorNPR-AsiRNA2.(c)Westernblotanalysisof
ES cells treated as described in panel a, showing a reduced level of the NPR-A
protein 48h after siRNA transfection. b-Actin was used as a loading control. Data
represent mean±S.D. (n¼3); *Po0.05 (two-tailed t-test)
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Cell Death and Diseasewere upregulated in ES cells treated with NPR-A siRNA
compared with control siRNA (Figures 3c and d). This
increase in multi-lineage-speciﬁc genes suggests that cells
were differentiated along several different pathways.
We next examined the differentiation potential of NPR-A-
deﬁcient ES cells by embryoid body (EB) formation in
the presence of retinoic acid (RA) (Supplementary Figure 2).
NPR-A siRNA-derived EBs were much smaller in size
compared with EBs derived from control siRNA-treated
cells (Supplementary Figure 2b). Although EBs derived from
both control siRNA and NPR-A siRNA started expressing
multipledifferentiationmarkersasexaminedbyRT-PCR,EBs
derived from NPR-A-deﬁcient cells expressed greater levels
of endoderm (GATA-4, GATA-6 and AFP), ectoderm (nestin)
and trophectoderm (Hand1 and Eomes) markers (Supple-
mentary Figure 2d). However, Brachyury, a marker of
mesoderm, was slightly reduced by NPR-A knockdown,
indicating that NPR-A knockdown predisposes ES cells to
endodermal, ectodermal and trophectodermal differentiation.
Pluripotency markers (such as Oct4 and Nanog) were
detected at higher levels in NPR-A siRNA-derived EBs than
in those of control siRNA-derived EBs (Supplementary
Figures 2c and e), most likely as a result of the incomplete
differentiation of a subset of cells.
NPR-A knockdown results in suppression of G1–S
transition. As a consequence of impairment in self-
renewing properties, we examined whether NPR-A
knockdown could also affect the proliferation of ES cells.
ES cells treated with control siRNA or NPR-A siRNA were
counted after 48h from siRNA transfection. NPR-A siRNA-
treated cells showed a signiﬁcant reduction in cell number
than did control siRNA-treated cells (Figure 4a), consistent
with the fact that they differentiate spontaneously.
Next, we evaluated whether downregulation of NPR-A
affected the ES cell cycle. We analyzed the phases of the cell
cycle 48h after siRNA transfection. The knockdown of NPR-A
expression induced a substantial accumulation of ES cells in
the G0/G1 phase, when compared with control siRNA-treated
cells (Figures 4b and c; Supplementary Figure 3). In addition,
NPR-A knockdown reduced the proportion of cells in the S
phase (Figures 4b and c). Thus, NPR-A knockdown in ES
cells inhibits ES cell proliferation by blocking cell-cycle
progression in G0/G1 and by preventing G1–S transition.
Figure 2 Knockdown of NPR-A reduces the potential for ES cell self-renewal. (a) Morphology of ES cells treated with control siRNA or NPR-A siRNAs at 2 days after
transfectioninthepresenceofLIF.(b)Self-renewalassay,AP-stainingofEScellstreatedasdescribedinpanela,4daysaftertransfection.(c)Immunoﬂuorescenceimagesof
EScellstreatedasinpanelafor72h,stainedwithantibodiesagainstOct4andcounterstainedwithHoechstreagent.(d)WesternblotanalysisofEScellstreatedasinpanela,
showing reduced protein levels of Oct4 and Nanog 72h after siRNA transfection. b-Actin was used as a loading control. (e) Left panels, photographs of the formed colonies
after6 daysfromculturingat lowdensityinthepresenceof LIF,stainedwithAP.APstainingof cellstreatedas inpanela.It mustbenoted thatthestainingintensityof NPR-A
siRNA-treated cells is decreased. Right panels, high-magniﬁcation images of AP staining. (f) Graph showing quantiﬁcation of the percentages of AP-positive colonies treated
as described in panel e. Data represent mean±S.D. (n¼2) and signiﬁcant values are indicated; **Po0.01, compared with control (two-tailed t-test). Scale bar¼50mm
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Cell Death and DiseaseTo further understand how loss of NPR-A could regulate
G1–S transition, we performed RT-PCR and real-time PCR
analyses of cells treated with control siRNA or NPR-A siRNA
for genes involved in the G1–S transition. Consistent with
changes in the cell cycle, knockdown of NPR-A led to a
downregulation in the transcription of cyclin D1, one of the
G1-phase cyclins, whereas transcription and proteins of p21
were upregulated (Figures 4d–f). These results suggest that
NPR-A suppresses inhibitors of the G1–S transition, allowing
rapid transition from mitosis to the S phase.
NPR-A knockdown inhibits PI3 signaling. We
investigated the effect of NPR-A knockdown on the
phosphoinositide 3-kinase (PI3K) signaling pathway, which is
critical for maintenance of murine ES cell pluripotency and self-
renewal,
25,26 by analyzing phosphorylation levels of Akt. We
found that knockdown of NPR-A dramatically reduced Akt
phosphorylation in comparison with controls (Figures 4g and h).
ANP is expressed in ES cells and promotes ES cell
pluripotency. We found that ANP was expressed in
undifferentiated ES cells (Oct4-positive cells), which were
cultured in the presence of LIF, as examined by
immunoﬂuorescence (Figure 5a), and that the expression
was downregulated upon differentiation, induced by culturing
ES cells without LIF for 5 days. The differentiated cells,
which were negative for Nanog expression, were
also negative for ANP expression (Figure 5a). Similar
results were obtained by western blotting (Figure 5b).
These results indicate that ANP is speciﬁcally expressed in
self-renewing ES cells. ANP knockdown in ES cells
affected ES cell self-renewal (Supplementary Information,
Supplementary Figure 4).
As NPR-A is expressed by undifferentiated ES cells,
24 it
suggests that these cells may be responsive to the NPR-A
ligand, ANP. ES cells cultured in a serum-free medium were
treatedwith2.5mMANPorvehicle,andthentheexpressionof
Oct4, Nanog and phosphorylated Akt was examined.
Real-time PCR analysis of ES cell pluripotency marker
genes, including Oct4 and Nanog, demonstrated a signiﬁcant
upregulationinthemRNAlevelsofOct4andNanog,12hafter
ANP treatment (Figure 5c). Furthermore, western blotting
showed a marked increase in the levels of Oct4 and a smaller
increase in Nanog levels in ANP-treated ES cells, compared
with control-treated cells after 12 and 24h (Figure 5d). In
addition, western blot analysis showed a marked upregulation
intheexpressionofphosphorylatedAktexaminedat12hfrom
ANP treatment (Figures 5e and f).
TodeterminetherelationshipbetweenANP/NPR-Aandthe
PI3K signaling pathway, we used LY294002, a speciﬁc
Figure 3 NPR-A knockdown decreases ES pluripotency genes and upregulates differentiation genes. (a) Real-time PCR of mRNA levels of pluripotency genes (Oct4,
NanogandSox2)aftertreatmentofEScellswithcontrolsiRNAorNPR-AsiRNA.(b)RT-PCRanalysisofEScellstreatedasdescribedinpanela,showingexpressionofstem
cell marker genes. GAPDH was used as the internal control. (c) Real-time PCR of ES cells treated as described in panel a, showing mRNA levels of the early differentiation
genes, GATA-4 (GATA-binding protein 4), GATA-6 (GATA-binding protein 6), AFP (a-fetoprotein), Brachyury, nestin, Cdx2 (caudal-type homeobox 2), Hand1 (heart and
neuralcrest derivatives expressedtranscript 1) andEomes (eomesodermin homolog).(d) RT-PCRanalysisof EScells treatedas describedin panel a, showingmRNAlevels
of the early differentiation genes. GAPDH was used as the internal control. Data represent mean±S.D. (n¼3); *Po0.05 (two-tailed t-test)
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Cell Death and Diseaseinhibitor of the PI3K pathway, to inhibit PI3K signaling.
26 ES
cells cultured in the presence of LIF were treated for 3 days
with ANP, LY294002 or ANP and LY294002 together. Control
and ANP-treated cells maintained undifferentiated morpho-
logy as indicated by strong AP staining, whereas ES cells
treated with LY294002 alone showed extensive differentiation
with negative AP staining. ANP- and LY294002-treated cells
showed a moderate differentiation and several colonies were
AP positive (Figure 5g).
PI3K signaling is required for Nanog expression, as a PI3K
inhibitor efﬁciently represses Nanog expression in ES cells.
26
In agreement, Nanog expression markedly reduced in cells
treated with LY294002 compared with control cells at 18h.
However, ES cells treated with ANP and LY294002 main-
tained Nanog expression at a higher level than did those
culturedinthepresenceofLY294002alone(Figures5handi),
indicating that the activation of NPR-A partially sustained ES
cell pluripotency in the presence of the PI3K inhibitor by
activating the Nanog expression.
Involvement of ANP receptor-mediated signaling in the
upregulation of Oct4 and Nanog was conﬁrmed using anantin
(a speciﬁc NPR-A antagonist), which blocked the effect of
ANP on the expression of Oct4 and Nanog when ES cells
were treated with 300nM anantin before ANP exposure
(Figures 6a and b). Furthermore, to test the possibility of
the involvement of PKG signaling in mediating ANP effect on
the expression of Oct4 and Nanog, we used KT5823 (a
speciﬁc inhibitor of PKG). Pretreatment with 2mM of the PKG
inhibitor 30min before ANP treatment, blocked the upregula-
tion of Oct4 and Nanog (Figures 6c and d), suggesting the
involvement of the NPR-A/PKG pathway in this process.
The effect of NPR-A/cGMP inhibitors on ES cell pluripo-
tency was examined by culturing ES cells in the presence of
anantin or KT5823 for 3 days in the serum-free medium. Both
inhibitors caused downregulation in the protein levels of Oct4
and Nanog (Figures 6e and f). These results conﬁrm the
involvement of the NPR-A/cGMP pathway in ES cell
pluripotency (Supplementary Figure 5).
Discussion
Here, we present evidence demonstrating that NPR-A is
critical for self-renewal and pluripotency of murine ES cells.
Our novel ﬁndings are summarized as follows: (1) Reduction
Figure 4 NPR-A knockdown reduced ES cell propagation, prolonged the G1 phase and upregulated phosphorylated Akt in murine ES cells. (a) Quantiﬁcationof ES cells
48haftertransfectionwithcontrolsiRNAorNPR-AsiRNA(n¼4).(b)EffectofNPR-Aknockdownoncell-cycleprogression,showingthepercentagesofcellsintheG1,Sand
G2/Mphasesofthecellcycle.(c)Quantiﬁcationofcell-cyclephases(n¼3).(d)RT-PCRanalysisofp21andcyclinD1mRNA48hafterEScelltransfectionwithcontrolsiRNA
or NPR-A siRNA. (e) Real-time PCR analysis of ES cells treated as described in panel d.( f) Western blot analysis for p21 48h after siRNA transfection. (g) Western blot
analysisfor phosphorylated Akt (Ser473; p-Akt) and totalAkt 48h after siRNA transfection. b-Actin was used as a loading control. (h) Relative levels of thep-Akt protein were
quantiﬁed after normalization to total Akt. Data represent mean±S.D. (n¼3); *Po0.05 or **Po0.01 (two-tailed t-test)
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Cell Death and Diseaseof NPR-A expression by siRNA in murine ES cells leads to
differentiation of ES cells in the presence of LIF. This
differentiation is accompanied by reduced expression of
Oct4, Nanog and Sox2, and induced expression of early
differentiation markers. (2) Knockdown of NPR-A accumu-
lates ES cells in the G1 phase of the cell cycle, and
downregulates phosphorylated Akt. (3) ANP is expressed in
undifferentiated ES cells, whereas its expression is reduced
afterEScelldifferentiation.(4)ExogenousANPstimulatesES
cell pluripotency factors (namely Oct4 and Nanog) and
upregulates phosphorylated Akt, involving the NPR-A/PKG
pathway.
We have previously shown that NPR-A is expressed in
pluripotent cells of the inner cell mass of the blastocyst and in
murine ES cells,
24 which implies that its loss may affect
development in vivo. These results are in agreement with a
recentstudyinmiceinwhichablationoftheNPR-Ageneledto
reduced viability of the embryo.
23 The linkage between
NPR-A expression in ES cells and embryonic development
strongly suggests that signaling through this receptor may
have a role in maintaining ES cell pluripotency. Interestingly,
our data revealed that ANP, the ligand for NPR-A, is
speciﬁcally expressed in self-renewing ES cells, suggesting
its involvement in mediating NPR-A function in ES cells.
Figure 5 ANP is expressed in murine ES cells, and exogenous ANP stimulatesES cell pluripotencyfactors. (a) Upper panels, double-immunoﬂuorescence images of ES
cells cultured in the presence of LIF, stained with antibodies against the ES cell markers, Oct4 and ANP. Lower panels, double-immunoﬂuorescence images of ES cells
cultured in the absence of LIF for 5 days, stained with antibodies against Nanog and ANP. It must be noted that ANP signals are downregulated upon differentiation.
(b)Westernblot analysisfor ANPofEScellstreatedasdescribedin panelsaandb.(c)Real-timePCRanalysisof mRNAlevels forpluripotencygenes12haftertreatmentof
ES cells with 2.5mM ANP. (d) Western blot analysis of Oct4 and Nanog in ES cells treated with ANP for 12 or 24h. b-Actin is shown as a control for loading. (e) Western blot
analysis for phosphorylated Akt (Ser473; p-Akt) and total Akt 12h after treatment of ES cells with ANP. (f) Relative levels of the p-Akt protein were quantiﬁed after normalized
to total Akt. (g) ES cells were treated with LY294002, ANP or ANPþLY294002 for 3 days, followed by staining for alkaline phosphatase (AP). (h) Western blot analysis of
NanoginEScellstreatedwithLY294002orANPþLY294002for18h.(i)Quantitativeanalysisofthewesternblotsasshowninpanelh.Datarepresentmean±S.D.(n¼3).
*Po0.05 or **Po0.01 (two-tailed t-test)
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Cell Death and DiseaseTherefore, we investigated the role of NPR-A in ES cells by
examining the effect of NPR-A knockdown, which markedly
induced differentiation of ES cells in the presence of LIF.
Conversely, exogenous ANP enhanced ES cell pluripotency
by inducing the expression of Oct4 and Nanog mRNA and
protein in serum-free media. The positive effect of ANP on the
expression of pluripotency markers was mainly dependent on
ANP binding to its speciﬁc receptor, NPR-A, involving the
cGMP/PKG pathway, as pretreatment with a speciﬁc NPR-A
antagonist (anantin) or a PKG inhibitor abrogated ANP-
induced upregulation of Oct4 and Nanog. These two
transcription factors, Oct4 and Nanog, work in concert to
maintain the undifferentiated state of ES cells.
4,5,7
As key regulators of ES cell self-renewal and pluripotency,
reducing either Nanog or Oct4 levels in ES cells triggers
differentiation.
9 Oct4 is a crucial regulator of ES cell
pluripotency, and acts as a gatekeeper to prevent ES cell
differentiation.
27 It has been shown that reduction of Oct4
expression below 50% of normal levels induces differentiation
of ES cells into the trophectoderm by upregulating the
transcription factor Cdx2.
4,28 Cdx2 and Oct4 also antagonize
each other at the transcription level.
29 In this study, knock-
down of NPR-A markedly reduced Oct4 expression and
induced the expression of the trophectodermal markers,
Cdx2, Hand1 and Eomes. These ﬁndings suggest that the
ANP/NPR-Asystemhasaroleinpreventingthedifferentiation
of ES cells into the trophectoderm by regulating Oct4
expression.
In murine ES cells, Nanog has been shown to block the
differentiation of ES cells into extraembryonic endoderm cells
byunknown mechanisms.
5,7 Inaddition, knockdown ofNanog
upregulates the expression of trophectodermal markers.
28
Overexpression of Nanog in mouse ES cells can maintain
them in a pluripotent state in the absence of LIF.
5,7 In this
study, knockdown of NPR-A markedly reduced the Nanog
expression at mRNA and protein levels, and induced the
expression of extraembryonic endoderm and trophecto-
dermal markers. In addition, treatment of ES cells with ANP
induced Nanog expression through an NPR-A-dependent
pathway, and ANP was able to maintain the Nanog expres-
sion in the presence of the PI3K inhibitor. Thus, we speculate
that ANP/NPR-A in ES cells contributes to maintaining the
undifferentiated state and supports ES cell self-renewal by
regulating Nanog expression.
Several of the known signaling pathways required for self-
renewalarealsoknowntoregulatethecellcycle,suggestinga
Figure 6 ANP upregulates Oct4 and Nanog through the NPR-A/PKG-dependent pathway. (a) Representative protein blot of Oct4 and Nanog proteins in ES cells treated
with vehicle, ANP alone or ANP and anantin. (b) Quantitative analysis of the western blots as shown in panel a.( c) Representative protein blot of Oct4 and Nanog proteins in
ES cells treated with vehicle, ANP alone or ANP and a PKG inhibitor (KT5823). (d) Quantitative analysis of the western blots as shown in panel c.( e) Western blot analysis of
Oct4 and Nanog in ES cells treated with anantin for 3 days. (f) Western blot analysis of Oct4 and Nanog in ES cells treated with KT5823 for 3 days. Data represent
mean±S.D. (n¼3). *Po0.05 or **Po0.01 (two-tailed t-test)
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Cell Death and Diseaselink between control of cell proliferation and self-renewal.
30
We found that knockdown of NPR-A inhibited ES cell
proliferation and induced cell-cycle arrest at the G1 phase.
Cell-cycle progression is controlled by cyclin-dependent
kinases,
31 and it is known that p21 has a critical role in the
regulation of the G1–S transition, in which it works as an
inhibitor of the G1 cyclin-dependent kinase–cyclin com-
plexes.
31 Consistent with these ﬁndings, NPR-A knockdown
led to an upregulation in the p21 transcript. Recently, it has
been found that Oct4 downregulation in ES cells upregulates
p21 and blocks cell-cycle progression in G0/G1, leading to
growth arrest,
32 suggesting that suppression of the G1–S
transition in NPR-A knockdown ES cells may be a conse-
quence of the downregulation of Oct4 expression.
ES cells are known to express D-type cyclins at very low
levels; expression of cyclin D1 is regulated by the PI3K-
dependent pathway, with a critical role in the G1–S transition
and maintenance of ES cell pluripotency.
25,26,33 Our data also
demonstrated that cyclin D1 and phosphorylated Akt are
downregulated as a result of NPR-A knockdown. In addition,
ES cells treated with ANP showed an increase in phosphory-
lated Akt, which is a downstream target of PI3K. Inhibition of
PI3K/Akt signaling in mouse ES cells suppresses proliferation
and induces differentiation of ES cells in the presence of
LIF.
25,26,33Furthermore,thePI3Ksignalingpathwayhasbeen
linked to ANP- and NPR-A-mediated cell proliferation in
endothelial cells.
34 These ﬁndings suggest that the PI3K
pathway is involved in the effect of the ANP/NPR-A signaling
system on ES cell pluripotency and self-renewal.
Although ANP and BNP share a common receptor
(NPR-A),
35 we found that ANP and BNP have different
functions in ES cells. In this study, ANP activated ES cell
pluripotencyfactors(namelyOct4andNanog)byitsbindingto
NPR-A. Furthermore, NPR-A knockdown led to differentiation
of ES cells. However, we previously demonstrated a role for
BNP signaling in the maintenance of murine ES cell
proliferation without affecting ES cell pluripotency.
24 These
results suggest that the effect of BNP in ES cells may be due
to its binding to NPR-B and not to NPR-A. There are several
studies showing similar ﬁndings in different cell types. For
example, it has been reported that mice with targeted deletion
of BNP
36 exhibit a different phenotype than do ANP-deﬁcient
mice.
37 This has led to the speculation that there may be a
separateunknownreceptorforBNPincardiacﬁbroblasts.
38In
addition, BNP increases bone growth by signaling through
NPR-B,
19,38 which is not affected by ANP.
39 Our ﬁndings from
a combination of ANP addition and NPR-A inhibition experi-
ments provide substantial evidence to support the hypothesis
thatANP signaling throughNPR-Ahas arole inrepressingES
cell differentiation.
In conclusion, we have demonstrated here for the ﬁrst time
that expression and activation of NPR-A are essential for
maintaining self-renewal and pluripotency of ES cells. Knock-
down of NPR-A represses the expression of genes encoding
the pluripotency factors, which would subsequently lead to
differentiation of ES cells. Our study also shows that
exogenous ANP positively regulates ES cell pluripotency,
involving its receptor NPR-A in a PKG-dependent manner
(Figure 7). Thus, maintaining an appropriate level of
endogenous NPR-A is critical for ES cell pluripotency.
The ﬁndings reported here provide novel molecular mechan-
isms involved in the self-renewal and pluripotency of ES cells.
Materials and Methods
ES cell culture. Murine ES cells (E14TG2a) (CRL-1821; American Type
Culture Collection, Manassas, VA, USA) were maintained in DMEM/F-12 medium
(Sigma, St. Louis, MO, USA), which was supplemented with 1000Units/ml LIF
(Chemicon, Temecula, CA, USA), 11% fetal bovine serum, 2mM L-glutamine
(Nacalai Tesque, Kyoto, Japan), 1mM sodium pyruvate (Sigma), 1% MEM
nonessential amino acids (Gibco, Carlsbad, CA, USA), 0.1mM 2-mercaptoethanol
(Sigma) and 1% penicillin–streptomycin. For siRNA transfection, ES cells were
culturedinthesamemedium,exceptthatfetalbovineserumwasreplacedwith15%
knockout serum replacement (Gibco). Murine ES cells were cultured under feeder-
free conditions in the presence of LIF. For differentiation, EBs were grown in
bacteriologic dishes without LIF for 4–5 days. Rat ANP (Sigma), anantin (Bachem,
Torrance, CA, USA), KT5823 (Calbiochem) and LY294002 (Calbiochem) were
added to cultured ES cells at 2.5, 300, 2 and 10mM respectively, whereas control
cells received vehicle alone.
In vitro differentiation. Undifferentiated ES cells were trypsinized and
resuspended in the ES cell culture medium without LIF. Differentiation was
induced by the hanging drop method as a standard method of EB formation, and
treatmentwithRAfor3days.EBswerefurtherculturedfor7daysinadifferentiation
medium.
Immunoﬂuorescence. ES cells grown on glass coverslips or 35-mm dishes
were rinsed brieﬂy with phosphate-buffered saline (PBS) and ﬁxed for 20min in 4%
paraformaldehyde in 0.1M phosphate buffer (pH 7.4). ES cells were permeabilized
for 10min with 0.1% Triton X-100 in PBS, and blocked for 40min with 4% bovine
serum albumin in PBS at room temperature. They were then incubated overnight at
41Cwiththefollowingantibodies:anti-ANP(1:500;PeptideOsakaInstitute,Osaka,
Japan), anti-ANP (1:300; sc-18811; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), anti-NPR-A (1:300; Abcam, Cambridge, UK), anti-Oct4 (1:200, sc-5279;
Santa Cruz Biotechnology) and anti-Nanog (1:2000, Bethyl Laboratories,
Montgomery, TX, USA). This was followed by incubation with the following
secondary antibodies: Alexa Fluor 594-labeled anti-goat IgG, Alexa Fluor 594-
labeled anti-mouse IgG, Alexa Fluor 488-labeled anti-mouse IgG and Alexa Fluor
488-labeled anti-rabbit IgG (all 1:400; Molecular Probes, Paisley, UK). Nuclei were
counterstained using Hoechst 33342 (1mg/ml; Invitrogen, Carlsbad, CA, USA).
Figure7 ProposedmodelofNPR-Asignaling-mediatedmaintenanceofEScell
self-renewal and pluripotency. Activation of NPR-A by ANP stimulates the cGMP/
PKG signaling pathway, leading to increased expressions of Oct4 and Nanog, and
reduced expression of p21, which in turn suppresses ES cell differentiation and
maintains ES cell pluripotency. In another pathway, binding of ANP to NPR-A
activates the phosphoinositide 3-kinase (PI3K) signaling pathway, which enhances
G1-to-S progression through induction of cyclin D1, and maintains pluripotency by
activation of Nanog expression
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Japan) or by confocal laser microscopy (C1si; Nikon, Tokyo, Japan), and images
were processed using Nikon EZ-C1 viewer software.
RT-PCR and real-time PCR. Total RNA was extracted using the RNeasy
Mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions.
cDNA synthesis was performed with 1mg of total RNA using the Superscript III ﬁrst-
strand cDNA synthesis kit (Invitrogen). The cDNA (0.5mg) was used as a template
inamixturethatcontainedAmpli-TaqGoldpolymerase(AppliedBiosystems,Foster
City, CA, USA). RT-PCR was performed with an annealing temperature of 581C.
cDNA samples were analyzed by real-time PCR in a LightCycler Real-Time PCR
System (Roche Diagnostics, Tokyo, Japan) using the SYBR Premix Ex Taq II
(Takara, Otsu, Japan).
The level of the different mRNAs was normalized to that of the housekeeping
gene,b-actin(see Supplementary Table1 forprimer sequences). A comparativeCt
(cycle time) analysis was used to determine fold changes in mRNA expression
based on the DDCt approach.
40 The reactions were carried out in triplicate.
RNA interference. RNA interference in murine ES cells was carried out
according to the manufacturer’s protocol using Lipofectamine RNAiMAX
(Invitrogen) in 6-well plates. Two pairs of siRNAs (Invitrogen) were designed for
NPR-A (NM_008727) using the BLOCK-iT RNAi Designer software (Invitrogen).
The appropriate siRNA-negative control Duplex (category no. 12935-300;
Invitrogen) was selected based on the percentage G/C. NPR-A siRNA and
controlsiRNA were transfectedat a ﬁnal concentration of 40mM for 24h in triplicate
for each treatment. At 48h after transfection, NPR-A knockdown was conﬁrmed by
RT-PCR,real-timePCRandwesternblotting.ThesequencesoftheNPR-AsiRNAs
were as follows:
NPR-A siRNA1: sense, 50-AGAUGUAGAUAACUCUGCCCUUGCG-30, anti-
sense, 50-CGCAAGGGCAGAGUUAUCUAUACAUCU-30; NPR-A siRNA2: sense,
50-GCCUUCAGGGUUGUCCUGAACUUUA-30; antisense, 50-UAAAGUUCAGGA
CAACCCUGAAGGC-30.
Western blotting. Total protein extracts were prepared from ES cells,
dissolved in SDS-PAGE buffer and transferred to nitrocellulose membranes
(Amersham Biosciences, Freiburg, Germany). Proteins were detected using
antibodies against NPR-A (1:1000, sc-31632; Santa Cruz Biotechnology),
phospho-Akt (1:1000, Ser473; Cell Signaling, Beverly, MA, USA), Akt (1:1000,
Ser473;CellSignaling),Oct4(1:1000,sc-5279;SantaCruzBiotechnology),Nanog
(1:8000, A300-397A; Bethyl Laboratories), ANP (1:1000, sc-18811; Santa Cruz
Biotechnology), p21 (1:1000, sc-397; Santa Cruz Biotechnology) and b-actin
(1:8000, sc-47778; Santa Cruz Biotechnology). The secondary antibodies were
peroxidase-conjugated anti-rabbit IgG, peroxidase-conjugated anti-goat IgG or
peroxidase-conjugated anti-mouse IgG (all 1:10000; Jackson ImmunoResearch
Lab Inc., Newmarket, UK). Blots were developed using SuperSignal West Pico
Chemiluminescent substrate (Pierce, Loughborough, UK), and visualized using an
LAS-3000 FujiFilm Lumino-Image Analyzer (FujiFilm, Tokyo, Japan).
Self-renewal assays. To determine the ability of ES cells to retain an
undifferentiated phenotype, self-renewal assays were performed using an AP kit
(Chemicon) as described previously.
24 AP-positive colonies were counted by
microscopic examination. Colonies of tightly packed and ﬂattened AP-positive cells
wereconsideredundifferentiated,andcoloniesofmixturesofunstainedandstained
cells and entirely unstained cells with ﬂattened irregular morphology were
considered differentiated.
Cell-cycle analysis. Cells were ﬁxed overnight in 70% ethanol at 41C.
Enzymatic removal of RNA was carried out using 100mg/ml RNase (Boehringer
Mannheim GmbH, Mannheim, Germany) at room temperature for 20min. Cells
were then stained with 5mg/ml propidium iodide (Sigma) at 41C for 40min. Flow-
cytometric analysis was carried out on 20000 gated events. Data acquisition was
performedusingaFACSCalibur(BDBiosciences,Oxford,UK),andcell-cyclephase
distribution was analyzed using ModFit LT ﬂow cytometry modeling software (Verity
Software House, Topsham, ME, USA).
Cell proliferation assay. To determine the number of cells, cells were
washed with PBS and trypsinized from the culture dishes. Cell suspension was
mixedwithtrypanbluesolution,andthenumberoflivecellswasdeterminedusinga
homocytometer. Cells failing to exclude the dye were considered nonviable.
Statistical analysis. The results are expressed as mean±S.D., as indicated
in the ﬁgure legends. Statistical signiﬁcance was assessed by two-tailed Student’s
t-tests. Values of Po0.05 were considered signiﬁcant.
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